AME - Educational Analysis * US Equities
Educational Analysis * US Equities

AME

Earnings behavior, post-earnings drift, and the gap between consensus and the market's real expectation - the educational primer before you look at the institutional verdict.

Educational content only - not investment advice. Nothing on this page is a recommendation to buy or sell any security. Historical patterns do not predict future outcomes. Consult a licensed financial advisor before making any trading decision.
Published byGamma QC editorial
TickerAME
CategoryEducational primer
Last reviewedNovember 17, 2026
You're viewing an older edition of this page.Read the latest edition →

Business profile & competitive position

AMETEK, Inc. (NYSE: AME) sits in the Industrials sector, specifically the Electrical Equipment & Parts industry, and operates as a global manufacturer of electronic instruments and electromechanical devices. Its business is split into two reporting segments: the Electronic Instruments Group (EIG), which builds advanced analytical, test, and measurement instruments for the process, aerospace, power, and industrial markets, and the Electromechanical Group (EMG), which supplies precision motion control solutions, highly engineered medical components and devices, thermal management systems, specialty metals, and electrical interconnects to aerospace and defense, medical, automation, and other industrial end markets.

The financial signature of that mix is relatively strong. The company currently carries a 19.9% net margin and a 14.7% ROE. Margins in the high teens are not common across the broad Industrials landscape, where pricing pressure and cyclical input costs frequently compress profitability. A mid-teens ROE suggests AMETEK is generating respectable returns on the capital shareholders have entrusted to management. Together, these figures point to a business with durable product differentiation—specialty instrumentation, motion control, and engineered medical components are typically not easily substitutable commodities—and disciplined capital allocation rather than purely volume-driven growth.

Financial posture

At the market-cap level, AMETEK is currently valued at $54.1 billion and trades at a P/E ratio of 33.1. That multiple is a meaningful premium to the industrials average and implies the market is pricing in above-average growth and cash-flow stability in exchange for current price. The valuation is not being supported by a leveraged capital structure, at least directionally; the company has historically operated with conservative balance-sheet settings, and its focus on cash generation is central to how management allocates resources.

Profitability quality matters here. A 19.9% net margin means nearly one in five dollars of revenue converts to bottom-line profit, while the 14.7% ROE indicates equity capital is working efficiently. The stock's beta of 0.97 also signals that AMETEK has moved roughly in line with the broader market—neither a high-beta cyclical proxy nor a defensive low-volatility name. For a company tied to aerospace, power, and industrial activity, that near-market beta is consistent with a diversified revenue stream that smooths out individual end-market wobbles.

Strategic priorities & outlook

AMETEK's most recent 10-K frames its operational identity around the AMETEK Growth Model, which targets high-single-digit annual sales growth, double-digit annual EPS growth, strong free cash flow generation, and a superior return on total capital. Supporting that model are three operational levers: operational excellence, strategic acquisitions, and global expansion.

On the operations side, the company emphasizes lean manufacturing, global sourcing, Design for Six Sigma, Value Engineering/Value Analysis, growth kaizens, and the integration of digitalization and artificial intelligence into its processes. These are not abstract efficiency buzzwords; they are the standard toolkit through which AMETEK attempts to protect its margin structure while expanding volume.

Acquisitions are the second leg. From 2021 through December 31, 2025, AMETEK completed 15 acquisitions with roughly $1.8 billion in annualized sales. In 2025 alone, the company deployed $933.2 million in cash, net of cash acquired, for two notable deals: Kern, a provider of high-precision machining and optical inspection solutions, and FARO Technologies, a 3D measurement and imaging solutions business. Those additions extend AMETEK's metrology and precision-engineering footprint, which aligns with its secular positioning in automation, aerospace quality assurance, and advanced manufacturing.

Geographically, AMETEK is leaning into best-cost manufacturing facilities in China, Czechia, Malaysia, Mexico, and Serbia to stay close to customers and capture international demand. In 2025, 52% of EIG's net sales and 42% of EMG's net sales went to customers outside the United States, so international execution is not a peripheral issue—it is central to revenue composition. The company finished 2025 with record operating income, net income, orders, and backlog, while sales reached $7,401.1 million, up 6.6% from 2024, and diluted EPS came in at $6.40, up 7.9%. AMETEK employed approximately 22,500 people as of December 31, 2025.

Macro & geopolitical exposure

Because AMETEK is classified in the Electrical Equipment & Parts industry within Industrials, its macro risk set is defined by the typical sensitivities of engineered-component and instrumentation businesses. That includes exposure to industrial capital spending, aerospace and defense procurement cycles, medical device demand, and broader automation trends. When factories, airlines, utilities, and defense programs invest in new equipment, AMETEK's test, measurement, motion-control, and thermal-management products generally benefit; when those budgets contract, order patterns can elongate.

The industry also carries relevant exposure to trade policy and tariffs, currency translation in international revenue, and supply-chain logistics. Specialized metals, semiconductors, and precision-machined components are inputs whose availability and cost can move with trade rules and commodity markets. In addition, aerospace, defense, and medical end markets are comparatively regulated, meaning product certifications and customer qualification timelines can influence how quickly revenue converts. AMETEK's deliberate geographic diversification through facilities in China, Czechia, Malaysia, Mexico, and Serbia is a direct response to these cross-border operating realities.

Recent developments

Recent news flow has been light but instructive. On November 11, 2026, defenseworld.net published a comparison of SMC and AMETEK, framing how the two industrial holdings stack up against one another. On November 9, 2026, Zacks ran a piece focused on AMETEK's international revenue trends and expectations, reinforcing the importance of the company's non-U.S. sales mix. The same day, PR Newswire reported that AMETEK had promoted John Henriques and Kevin Coleman to Senior Vice Presidents, signaling internal leadership continuity. On November 6, 2026, the company announced its latest quarterly dividend via PR Newswire. None of these headlines carried material earnings-altering news, but they illustrate a company that is actively managing its investor narrative around global sales, leadership pipeline, and shareholder returns.

Earnings behavior & post-earnings drift

AMETEK has compiled a near-perfect earnings record over the last eight reported quarters, beating consensus estimates in all eight, for a 100% beat rate, with an average surprise of +4.3%. That consistency is notable. However, the post-earnings price behavior does not follow the intuitive script that "beat means pop." Across those same eight quarters, the average 5-day post-earnings price move was -0.43%, which is classified as essentially flat. The pattern suggests that AMETEK's beats are largely anticipated and priced in ahead of the release, leaving little follow-through buying once the numbers are confirmed.

The last four reported quarters illustrate that disconnect clearly. On November 3, 2026, AMETEK reported EPS of $2.21 against an estimate of $2.11, a 4.7% positive surprise, yet the stock fell 4.62% the next day and 4.13% over the following five sessions. On August 4, 2026, EPS of $2.09 beat the $1.99 estimate by 5.0%; the stock was up just 0.28% the next day and 0.89% over five days. The April 30, 2026 report delivered $1.97 versus $1.90, a 3.7% beat, but the stock dropped 2.13% the next day and 0.33% over five days. The February 3, 2026 quarter—$2.01 versus $1.94, a 3.6% beat—saw a -0.48% one-day move but a +1.83% five-day move.

One takeaway from this sequence is that AMETEK's strong beat history reflects execution against expectations, not necessarily surprises that re-rate the stock higher. The market's real expectation appears to bake in upside, so the release often becomes a "sell the news" event rather than a catalyst for further gains. The next scheduled report is February 2, 2027, before the market open, with a consensus EPS estimate of $2.28. With the current price at $235.75, the RSI near neutral at 44.8, and the 50-day EMA at $242.23, the tape heading into that print shows a stock that has recently slipped below its short-term moving average despite the steady earnings outperformance.

Frequently Asked Questions

What does AMETEK actually make?

AMETEK manufactures electronic instruments and electromechanical devices through two segments. EIG produces analytical, test, and measurement instruments for process, aerospace, power, and industrial markets. EMG supplies precision motion control, medical components, thermal management systems, specialty metals, and electrical interconnects for aerospace, defense, medical, automation, and industrial uses.

How has AMETEK performed around recent earnings?

Over the last eight quarters, AMETEK has beaten consensus EPS estimates 100% of the time, with an average surprise of +4.3%. However, the average 5-day post-earnings price move has been -0.43%, classified as flat, meaning the beats have generally not produced sustained follow-through rallies.

What are AMETEK's key strategic priorities?

The company is executing the AMETEK Growth Model, targeting high-single-digit annual sales growth, double-digit annual EPS growth, strong cash flow, and superior return on total capital. It also pursues operational excellence through lean manufacturing and digitalization, strategic acquisitions, and global expansion via manufacturing facilities in China, Czechia, Malaysia, Mexico, and Serbia.

For a deeper dive, consider reviewing the full institutional verdict and analyst-model consensus surrounding AMETEK before the next earnings cycle.

Real Data - Gamma QC Earnings IntelligenceAs of Nov 17, 2026
AMETEK, Inc. · Industrials / Electrical Equipment & Parts
$54.1BMarket cap
33.1P/E
19.9%Net margin
14.7%ROE
100%Beat rate, last 8Q
4.3%Avg EPS surprise
-0.43%Avg 5-day move after earnings
2027-02-02Next earnings
ReportedActualEstimateSurprise1D Move5D Move
2026-11-03$2.21$2.11+4.7%-4.62%-4.13%
2026-08-04$2.09$1.99+5%+0.28%+0.89%
2026-04-30$1.97$1.9+3.7%-2.13%-0.33%
2026-02-03$2.01$1.94+3.6%-0.48%+1.83%
2025-10-30$1.89$1.76+7.4%--
2025-07-31$1.78$1.69+5.3%--

Previous AME editions

Beyond the primer

Get the institutional verdict on AME

Seven-seat 21-ERT council. Pre-print forecast signed before the earnings release. Post-print grade, published in public. Every verdict sealed with a cryptographic receipt.

Read the AME verdict at Gamma QC
$49 Pro / $249 RIA * gammaqc.com

Verify authenticity

Every Gamma QC verdict is signed with a cryptographic receipt at issuance. Independently verify any published verdict at attest.gammaqc.com. This educational primer is content-only and not itself signed; the institutional verdict at the link above is.